Graf Akcie ADMA (Adma Biologics Inc). Diskuze k akciím ADMA. Aktuální informace ADMA.

Základní informace o společnosti Adma Biologics Inc (Akcie ADMA)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 145.5M
Hodnota podniku (EV) N/A
Tržby 58.112M
EBITDA N/A
Zisk -73.61
Růst v tržbách Q/Q 128.96 %
Růst v tržbách Y/Y 56.02 %
P/E (Cena vůči ziskům) 0.00
Forward P/E 0.63
EV/Sales 4.05
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 2.50
P/FCF N/A
Price/Book 1.65
Účetní hodnota na akcii 0.67
Hotovost na akcii 0.43
FCF vůči ceně -92.85 %
Počet zaměstnanců 407
Tržba na zaměstnance 142.780k
Profit margin -179.41 %
Operating margin -106.29 %
Gross margin -45.17 %
EBIT margin -104.91 %
EBITDA margin -94.70 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -39.13 %
EPS - Očekávaný růst příští rok -21.05 %
Return on assets -34.00 %
Return on equity -76.73 %
ROIC -38.10 %
ROCE -28.41 %
Dluhy/Equity 1.35
Čistý dluh/EBITDA -2.89
Current ratio 9.42
Quick Ratio 3.94
Volatilita 5.05
Beta 0.77
RSI 38.60
Cílová cena analytiků 8
Známka akcie (dle analytiků) 1.33
Insider ownership 1.92 %
Institutional ownership 42.70 %
Počet akcií 132.769M
Procento shortovaných akcií 11.69 %
Short ratio 5.64 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2013
Země United States

Finanční výsledky akcie ADMA

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$29.349$16.985$22.761$10.661$7.178$5.916$3.068$1.118
Cost Of Goods Sold$39.504$42.195$29.164$6.361$4.312$3.742$2.023$0.669
Gross Profit$-10.155$-25.209$-6.404$4.3$2.866$2.173$1.044$0.449
Research And Development Expenses$2.344$3.926$5.57$7.688$7.016$9.517$9.303$3.469
SG&A Expenses$25.911$22.503$18.752$8.495$6.746$4.824$4.365$3.142
Other Operating Income Or Expenses$-2.17$-7.806$-7.349$-5.448$-4.618$-3.851$-2.418$-1.747
Operating Expenses$70.773$77.274$62.071$27.991$22.691$21.934$18.11$9.027
Operating Income$-41.424$-60.289$-39.31$-17.33$-15.514$-16.019$-15.042$-7.909
Total Non-Operating Income/Expense$-6.855$-5.455$-4.449$-2.185$-2.456$-1.346$-0.485$-0.01
Pre-Tax Income$-48.279$-65.743$-43.759$-19.515$-17.97$-17.365$-15.527$-7.919
Income Taxes-----$-0.552-$-0.618
Income After Taxes$-48.279$-65.743$-43.759$-19.515$-17.97$-16.813$-15.527$-7.301
Other Income--------
Income From Continuous Operations$-48.279$-65.743$-43.759$-19.515$-17.97$-16.813$-15.527$-7.301
Income From Discontinued Operations--------
Net Income$-48.279$-65.744$-43.759$-19.515$-17.97$-16.813$-15.527$-7.301
EBITDA$-37.129$-55.881$-35.979$-16.327$-14.778$-15.587$-14.685$-7.722
EBIT$-41.424$-60.289$-39.31$-17.33$-15.514$-16.019$-15.042$-7.909
Basic Shares Outstanding5445231210975
Shares Outstanding5445231210975
Basic EPS$-0.89$-1.45$-1.91$-1.61$-1.73$-1.81$-2.38$-1.39
EPS - Earnings Per Share$-0.89$-1.45$-1.91$-1.61$-1.73$-1.81$-2.38$-1.39
# 2020 2019 2018 2017 2016 2015
Current Ratio6.11784.62646.60391.92975.04935.7381
Long-term Debt / Capital0.76340.6770.49921.56680.94560.7087
Debt/Equity Ratio3.23482.09730.997-4.135417.41662.4354
Gross Margin-34.6013-148.4187-28.135440.336439.93236.7367
Operating Margin-141.1435-354.9479-172.711-162.5583-216.141-270.7871
EBIT Margin-141.1435-354.9479-172.711-162.5583-216.141-270.7871
EBITDA Margin-126.5071-328.9977-158.0759-153.1437-205.8894-263.4967
Pre-Tax Profit Margin-164.5003-387.061-192.2579-183.0512-250.3601-293.5467
Net Profit Margin-164.5002-387.0611-192.2579-183.0511-250.3601-284.22
Asset Turnover0.23090.19110.21070.45010.30270.2189
Inventory Turnover Ratio0.74452.26662.30951.2671.25122.1901
Receiveable Turnover8.458112.19825.865910.47237.764115.4066
Days Sales In Receivables43.153729.922462.224134.85447.011423.6911
ROE - Return On Equity-184.3204-332.5342-108.4949437.8284-2188.849-279.8159
Return On Tangible Equity-247.5333-537.2728-136.9441437.8282-2188.854-279.816
ROA - Return On Assets-37.9881-73.9717-40.5105-82.3943-75.7761-62.2168
ROI - Return On Investment-43.6148-107.416-54.3296-248.1461-118.9712-81.5052
Book Value Per Share0.44160.42650.89-0.34590.07660.6466
Operating Cash Flow Per Share-0.0150.2409-0.1247-0.02240.10170.0845
Free Cash Flow Per Share-0.03870.3114-0.2355-0.0260.3493-0.1355

Porovnání s konkurencí: Akcie ADMA

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
ADMA 0.00 N/A 56.02 % -21.05 % -76.73 % 1.65 -179.41 %
Akcie NVAX N/A N/A 2,252.66 % 21.81 % -150.88 % 19.13 -87.94 %
Akcie RGEN 145.78 3.82 68.12 % 60.00 % 6.88 % 9.64 16.36 %
Akcie RGEN 145.78 3.82 68.12 % 60.00 % 6.88 % 9.64 16.36 %

Nedávné obchody insiderů: Akcie ADMA

Jméno Obchod Cena Objem
Advisors Llcperceptive Life...
Nákup
19 Mar 2020
$2.10 $1,050,000
James Mond
EVP, CSO, and CMO
Nákup
10 Aug 2020
$2.88 $20,160
Adam S Grossman
President and CEO
Nákup
10 Aug 2020
$3.04 $18,240
Brian Lenz
EVP and CFO
Nákup
11 Aug 2020
$2.97 $11,880
Jerrold B Grossman
Director
Nákup
12 Aug 2020
$2.89 $29,478
Martha J Demski
Director
Nákup
13 Aug 2020
$2.88 $5,760
Jerrold B Grossman
Director
Nákup
21 Aug 2020
$2.56 $13,568
Adam S Grossman
President and CEO
Nákup
8 Sep 2020
$2.24 $8,960
James Mond
EVP, CSO, and CMO
Nákup
8 Sep 2020
$2.20 $8,800
Jerrold B Grossman
Director
Nákup
10 Sep 2020
$2.22 $11,100
Martha J Demski
Director
Nákup
11 Sep 2020
$2.29 $5,038
Advisors Llcperceptive Life...
Nákup
19 Mar 2020
$2.10 $1,050,000
James Mond
EVP, CSO, and CMO
Nákup
10 Aug 2020
$2.88 $20,160
Adam S Grossman
President and CEO
Nákup
10 Aug 2020
$3.04 $18,240
Brian Lenz
EVP and CFO
Nákup
11 Aug 2020
$2.97 $11,880
Jerrold B Grossman
Director
Nákup
12 Aug 2020
$2.89 $29,478
Martha J Demski
Director
Nákup
13 Aug 2020
$2.88 $5,760
Jerrold B Grossman
Director
Nákup
21 Aug 2020
$2.56 $13,568
Adam S Grossman
President and CEO
Nákup
8 Sep 2020
$2.24 $8,960
James Mond
EVP, CSO, and CMO
Nákup
8 Sep 2020
$2.20 $8,800
Jerrold B Grossman
Director
Nákup
10 Sep 2020
$2.22 $11,100
Martha J Demski
Director
Nákup
11 Sep 2020
$2.29 $5,038

Diskuze k akciím ADMA